[
    [
        {
            "time": "2023-02-05",
            "original_text": "涨停板早知道：七大利好有望发酵",
            "features": {
                "keywords": [
                    "涨停板",
                    "利好",
                    "发酵"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "涨停板早知道：七大利好有望发酵",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-02-05",
            "original_text": "贝达药业：BPI-27336药品临床试验申请受理 拟用于实体瘤治疗",
            "features": {
                "keywords": [
                    "贝达药业",
                    "BPI-27336",
                    "临床试验",
                    "实体瘤",
                    "受理"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：BPI-27336药品临床试验申请受理 拟用于实体瘤治疗",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-05",
            "original_text": "贝达药业：创新药BPI-27336药品临床试验申请获得受理",
            "features": {
                "keywords": [
                    "贝达药业",
                    "BPI-27336",
                    "创新药",
                    "临床试验",
                    "受理"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：创新药BPI-27336药品临床试验申请获得受理",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-05",
            "original_text": "贝达药业：申报的BPI-27336片的药品临床试验申请已经获得国家药品监督管理局受理",
            "features": {
                "keywords": [
                    "贝达药业",
                    "BPI-27336",
                    "药品",
                    "临床试验",
                    "受理",
                    "国家药品监督管理局"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：申报的BPI-27336片的药品临床试验申请已经获得国家药品监督管理局受理",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]